Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes

Maya Margalit1, Samir Abu Gazala, Shwaqi J. Ghazala, Ruslana Alper, Eran Elinav, Andreas Klein, Victoria Doviner, Yoav Sherman, Barbara Thalenfeld, Dean Engelhardt, Elazar Rabbani, Yaron Ilan
1Liver Unit, Department of Medicine, Hadassah University Hospital, Jerusalem, Israel

Tóm tắt

Concanavalin A (ConA) induces natural killer T (NKT) cell-mediated liver damage. Glucocerebroside (GC) is a naturally occurring glycolipid. Our aims were to determine the effect of GC in a murine model of ConA-induced hepatitis. Mice in groups A and B were treated with GC 2 h before and 2 h following administration of ConA, respectively; group C mice were treated with ConA; group D mice was treated with GC; group E mice did not receive any treatment. Liver damage was evaluated by serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and liver histology. The immune effect of GC was determined by fluorescence-activated cell sorter analysis of intrahepatic and intrasplenic NKT lymphocytes, measurement of cytokine levels, and Western blot analysis for STAT 1, 4, 6, and NF-κB expression. The effect of GC on NKT cell proliferation was assessed in vitro. Serum AST and ALT levels were markedly reduced in GC-treated group A mice compared with nontreated group C animals, and histological damage was markedly attenuated in group A. The beneficial effect of GC was associated with a 20% decrease of intrahepatic NKT lymphocytes, significant lowering of serum IFN-γ levels, and decreased STAT1 and STAT6 expression. In vitro administration of GC led to a 42% decrease of NKT cell proliferation in the presence of dendritic cells but not in their absence. Intraperitoneally administered radioactive GC was detected in the liver and bowel. Administration of GC led to amelioration of ConA hepatitis associated with an inhibitory effect on NKT lymphocytes. GC holds promise as a new immune-modulatory agent.

Từ khóa


Tài liệu tham khảo

10.1126/science.1700477

Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, and Kronenberg M.Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.J Immunol161: 5124–5128, 1998.

Burstein Y, Zakuth V, Rechavi G, and Spirer Z.Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.J Clin Lab Immunol23: 149–151, 1987.

Chen Hand Paul WE.Cultured NK1.1+CD4+ T cells produce large amounts of IL-4 and IFNγ upon activation by anti-CD3 or CD1.J Immunol159: 2240, 1997.

10.4049/jimmunol.171.8.4020

10.3109/08916939908994050

10.1016/S1074-7613(00)80617-2

10.2165/00128072-200204070-00001

10.1016/S1471-4906(03)00162-5

10.1073/pnas.040561297

Gantner F, Leist M, Lohse AW, Germann PG, and Tiegs G.Concanavalin A-induced T cell mediated hepatic injury in mice: The role of tumor necrosis factor.Hepatology21: 190–198, 1995.

10.1016/S0167-5699(00)01735-7

10.1016/S0952-7915(00)00243-0

10.1002/hep.510290605

10.1084/jem.191.1.105

10.1016/S0002-9440(10)64540-3

10.1126/science.278.5343.1626

Kawano T, Nakayama T, and Kamada N.Antitumor cytotoxicity mediated by ligand-activated human Valpha24 NKT cells.Cancer Res59: 5102, 1999.

10.1016/S1471-4906(02)02323-2

Kudo D, Rayman P, Horton C, Cathcart MK, Bukowski RM, Thornton M, Tannenbaum C, and Finke JH.Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells.Cancer Res63: 1676–1683, 2003.

Kuske TTand Rosenberg A.Quantity and fatty acyl composition of the glycosphingolipids of Gaucher spleen.J Lab Clin Med80: 523–529, 1972.

10.1053/gast.1996.v111.pm8690213

10.1016/S1091-255X(02)00126-9

Lucci A, Cho WI, Han TY, Giuliano AE, Morton DL, and Cabot MC.Glucosylceramide: a marker for multiple-drug resistant cancers.Anticancer Res18: 475–480, 1998.

Margalit M, Zolotarov L, Hemed N, Elstein D, Zimran A, and Ilan Y.Glucocerebroside induces altered anti hepatitis C immunity in patients with Gaucher's disease (Abstract).Hepatology38: 490A, 2003.

10.1002/ajh.2830290403

10.4049/jimmunol.170.11.5429

10.1084/jem.179.5.1529

10.1016/S1074-7613(01)00132-7

10.4049/jimmunol.166.11.6578

10.1053/jhep.2000.17701

10.1006/cyto.1999.0561

Nishimura Tand Ohta A.A critical role for antigen specific Th1 cells in acute liver injury in mice.J Immunol162: 6503–6509, 1999.

Ogasawara K, Takeda K, Hashimoto W, Satoh M, Okuyama R, Yanai N, Obinata M, Kumagai K, Takada H, Hiraide H, and Seki S.Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction.J Immunol160: 3522–3527, 1998.

10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3

10.1016/0006-2952(88)90271-7

10.1016/S0002-9440(10)64804-3

Shamshiev A, Donda A, Prigozy TI, Mori L, Chigorno V, Benedict CA, Kappos L, Sonnino S, Kronenberg M, and De Libero G.The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides.Immunity13: 2552–2564, 2000.

10.4049/jimmunol.169.3.1340

Siebler J, Wirtz S, Klein S, Protschka M, Blessing M, Galle PR, and Neurath MF.A key pathogenic role for the STAT1/T-bet signaling pathway in T-cell-mediated liver inflammation.Hepatology38: 1573–1580, 2003.

10.1073/pnas.0430327100

10.1002/(SICI)1096-9888(200003)35:3<347::AID-JMS941>3.0.CO;2-3

Takahashi M, Ogasawara K, Takeda K, Hashimoto W, Sakihara H, Kumagai K, Anzai R, Satoh M, and Seki S.LPS induces NK1.1+αβ T cells with potent cytotocicity in the liver of mice via production of IL12 from Kupffer cells.J Immunol156: 2436–2442, 1996.

10.1073/pnas.040566697

10.1038/ni1203-1164

10.1038/82771

Tiegs G.T cells, NKT cells and NK cells in an experimental model of autoimmune hepatitis. In:Liver Immunology, edited by Gershwin ME, Vierling JM, and Manns MP. Philadelphia: Hanley & Belfus, 2003, p. 171–183.

Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, Hiraide H, Uchiyama M, and Abo T.Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.J Immunol159: 1537–1542, 1997.

10.1002/hep.510290334

10.1002/hep.510280303

10.1073/pnas.1833166100

10.1034/j.1600-0676.2000.020005357.x

10.1126/science.1103440